GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...

AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially ...

Is Eli Lilly a good stock to buy on the dip? On Jan. 14, CEO David Ricks told investors that 2024 sales would come in at about $45 billion. We recently published a list of Jim Cramer Discussed ...

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...

Eli Lilly has called on financial regulators ... The pharma group’s chief executive, David Ricks, has told the Financial Times that the authorities should examine the deal closely, given that ...

Pleasant Plains girls basketball will play for its sixth Sangamon County Tournament title on Thursday, plus other week's top ...

Microsoft boguht 240 acres in Kenosha, Wis. for future data center development, a boost for local innovation and economic ...